Mark Raza Principal Deputy Chief Counsel - FDA | Official Website
Mark Raza Principal Deputy Chief Counsel - FDA | Official Website
This is a 62.5% decrease from the number of companies inspected in the previous quarter, when eight companies received eight inspections.
The companies inspected were involved in either the Biologics, Food and Cosmetics, or Devices sectors.
All of the companies were in line with FDA regulations, and don't need to adjust their managing operations or regulatory/administrative actions.
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
The FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.
| Company Name | Area of Business | Inspection Date | Result |
|---|---|---|---|
| Lumendi, LLC | Devices | 01/16/2024 | No Action Indicated (NAI) |
| Mifusa Delica North America, Inc. | Food and Cosmetics | 03/13/2024 | No Action Indicated (NAI) |
| Park Avenue Fertility and Reproductive Medicine | Biologics | 01/04/2024 | No Action Indicated (NAI) |
Alerts Sign-up